Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals

Anna Perkinson, Jeffrey Lakritz, William D Wilson, Antoinette Marsh, Judy Mihalyi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elimination half-life, and mean residence time were determined from concentration versus time curves. Maximum peak concentration of erythromycin A (0.45 ± 0.27 μg/ml) after administration of erythromycin ethylsuccinate was observed at 2.38 ± 1.54 hours after treatment. Concentrations of anhydroerythromycin A were maximal at 2.2 ± 2.0 hours and reached a maximum of 2.6 ± 1.9 μg/ml. Plasma concentrations of the ester parent drug (erythromycin ethylsuccinate) were below the limit of quantitation (0.1 μg/ml) at all times except 2.5, 2.75, and 5.5 hours. Levels at those times ranged from 0.1 to 0.144 μg/ml. Erythromycin ethylsuccinate appears to be poorly absorbed after oral administration to fasted foals. Plasma concentrations of erythromycin A remained below 0.25 μg/ml (reported minimum inhibitory concentration for Rhodococcus equi) for less than 4 hours after intragastric administration of erythromycin ethylsuccinate, suggesting that the recommended dosage (25 mg/kg every 6 hours) would be suboptimal for treatment of R. equi infections.

Original languageEnglish (US)
JournalVeterinary Therapeutics
Volume3
Issue number2
StatePublished - 2002

Fingerprint

Erythromycin Ethylsuccinate
intragastric administration
erythromycin
foals
pharmacokinetics
Pharmacokinetics
Erythromycin
Rhodococcus equi
Microbial Sensitivity Tests
Pharmaceutical Preparations
drugs
Oral Administration
Half-Life
Esters
High Pressure Liquid Chromatography
Body Weight
minimum inhibitory concentration
oral administration
half life
hay

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals. / Perkinson, Anna; Lakritz, Jeffrey; Wilson, William D; Marsh, Antoinette; Mihalyi, Judy.

In: Veterinary Therapeutics, Vol. 3, No. 2, 2002.

Research output: Contribution to journalArticle

Perkinson, Anna ; Lakritz, Jeffrey ; Wilson, William D ; Marsh, Antoinette ; Mihalyi, Judy. / Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals. In: Veterinary Therapeutics. 2002 ; Vol. 3, No. 2.
@article{9668f5c144694496b1c4720ba2cd64a5,
title = "Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals",
abstract = "Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elimination half-life, and mean residence time were determined from concentration versus time curves. Maximum peak concentration of erythromycin A (0.45 ± 0.27 μg/ml) after administration of erythromycin ethylsuccinate was observed at 2.38 ± 1.54 hours after treatment. Concentrations of anhydroerythromycin A were maximal at 2.2 ± 2.0 hours and reached a maximum of 2.6 ± 1.9 μg/ml. Plasma concentrations of the ester parent drug (erythromycin ethylsuccinate) were below the limit of quantitation (0.1 μg/ml) at all times except 2.5, 2.75, and 5.5 hours. Levels at those times ranged from 0.1 to 0.144 μg/ml. Erythromycin ethylsuccinate appears to be poorly absorbed after oral administration to fasted foals. Plasma concentrations of erythromycin A remained below 0.25 μg/ml (reported minimum inhibitory concentration for Rhodococcus equi) for less than 4 hours after intragastric administration of erythromycin ethylsuccinate, suggesting that the recommended dosage (25 mg/kg every 6 hours) would be suboptimal for treatment of R. equi infections.",
author = "Anna Perkinson and Jeffrey Lakritz and Wilson, {William D} and Antoinette Marsh and Judy Mihalyi",
year = "2002",
language = "English (US)",
volume = "3",
journal = "Veterinary therapeutics : research in applied veterinary medicine",
issn = "1528-3593",
publisher = "Veterinary Learning Systems",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals

AU - Perkinson, Anna

AU - Lakritz, Jeffrey

AU - Wilson, William D

AU - Marsh, Antoinette

AU - Mihalyi, Judy

PY - 2002

Y1 - 2002

N2 - Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elimination half-life, and mean residence time were determined from concentration versus time curves. Maximum peak concentration of erythromycin A (0.45 ± 0.27 μg/ml) after administration of erythromycin ethylsuccinate was observed at 2.38 ± 1.54 hours after treatment. Concentrations of anhydroerythromycin A were maximal at 2.2 ± 2.0 hours and reached a maximum of 2.6 ± 1.9 μg/ml. Plasma concentrations of the ester parent drug (erythromycin ethylsuccinate) were below the limit of quantitation (0.1 μg/ml) at all times except 2.5, 2.75, and 5.5 hours. Levels at those times ranged from 0.1 to 0.144 μg/ml. Erythromycin ethylsuccinate appears to be poorly absorbed after oral administration to fasted foals. Plasma concentrations of erythromycin A remained below 0.25 μg/ml (reported minimum inhibitory concentration for Rhodococcus equi) for less than 4 hours after intragastric administration of erythromycin ethylsuccinate, suggesting that the recommended dosage (25 mg/kg every 6 hours) would be suboptimal for treatment of R. equi infections.

AB - Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elimination half-life, and mean residence time were determined from concentration versus time curves. Maximum peak concentration of erythromycin A (0.45 ± 0.27 μg/ml) after administration of erythromycin ethylsuccinate was observed at 2.38 ± 1.54 hours after treatment. Concentrations of anhydroerythromycin A were maximal at 2.2 ± 2.0 hours and reached a maximum of 2.6 ± 1.9 μg/ml. Plasma concentrations of the ester parent drug (erythromycin ethylsuccinate) were below the limit of quantitation (0.1 μg/ml) at all times except 2.5, 2.75, and 5.5 hours. Levels at those times ranged from 0.1 to 0.144 μg/ml. Erythromycin ethylsuccinate appears to be poorly absorbed after oral administration to fasted foals. Plasma concentrations of erythromycin A remained below 0.25 μg/ml (reported minimum inhibitory concentration for Rhodococcus equi) for less than 4 hours after intragastric administration of erythromycin ethylsuccinate, suggesting that the recommended dosage (25 mg/kg every 6 hours) would be suboptimal for treatment of R. equi infections.

UR - http://www.scopus.com/inward/record.url?scp=79251470803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251470803&partnerID=8YFLogxK

M3 - Article

C2 - 19750750

AN - SCOPUS:79251470803

VL - 3

JO - Veterinary therapeutics : research in applied veterinary medicine

JF - Veterinary therapeutics : research in applied veterinary medicine

SN - 1528-3593

IS - 2

ER -